Results 251 to 260 of about 38,150,648 (264)

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Social determinants of health and US cancer screening interventions: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Ariella R Korn   +2 more
exaly  

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Leticia Nogueira, Xuesong Han
exaly  

Innovations in research and clinical care using patient-generated health data

Ca-A Cancer Journal for Clinicians, 2020
Brian D. Gonzalez   +2 more
exaly  

Talking with adolescent and young adult cancer survivors about health after cancer: A review and communication guide for clinicians

Ca-A Cancer Journal for Clinicians
Catherine Benedict   +2 more
exaly  

Home - About - Disclaimer - Privacy